Biomarker analysis associated with diagnostic, recurrence, and therapeutic effects in pancreatic cancer and biliary tract cancer

Biomarker analysis associated with diagnostic, recurrence, and therapeutic effects in pancreatic cancer and biliary tract cancer - Biomarker analysis associated with diagnostic, recurrence, and therapeutic effects in pancreatic cancer and biliary tract cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044430

Enrollment

100

Registered

2021-06-04

Start date

2021-06-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer Biliary tract cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Diagnosed or clinically suspected pancreatic cancer or biliary tract cancer patients. 2) Scheduled treatment at our hospital 3) The consent has been obtained 4) 20 years old and over

Exclusion criteria

Exclusion criteria: 1) Have a history or complication of other cancers 2) Judged as lacking consent due to dementia or mental illness 3)Patients who have decided inappropriate to include in this study by the investigators

Design outcomes

Primary

Measure	Time frame
1) Small RNAs associated with diagnosis 2) Investigate the relationship between the following items and the expression status of small RNAs <Patient background> Patient age, gender, primary site, stage, treatment method and information on results and course, information on recurrence and metastasis, information on unfollowable or termination due to transfer, etc.	—

Countries

Japan

Contacts

Public ContactMorie Nishiwaki

MiRTeL Co.Ltd. Research and Development Division

kenkyu@mirtel.co.jp082-546-9797

Outcome results